National Bankshares Cuts DRI Healthcare Trust (TSE:DHT.UN) Price Target to C$17.50

DRI Healthcare Trust (TSE:DHT.UN) had its price target cut by National Bankshares from C$19.50 to C$17.50 in a research report released on Thursday,BayStreet.CA reports. They currently have an outperform rating on the stock.

DHT.UN has been the topic of a number of other reports. Raymond James cut their price objective on DRI Healthcare Trust from C$23.00 to C$22.00 in a research note on Wednesday, November 13th. CIBC lowered their price target on shares of DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating for the company in a report on Thursday, December 12th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, DRI Healthcare Trust presently has an average rating of “Moderate Buy” and a consensus price target of C$17.94.

DRI Healthcare Trust Stock Down 0.2 %

Shares of TSE:DHT.UN opened at C$11.83 on Thursday. The business has a fifty day simple moving average of C$11.97 and a 200 day simple moving average of C$12.57. DRI Healthcare Trust has a 12-month low of C$10.39 and a 12-month high of C$17.43.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.